| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |